uploads/2015/11/chart-11.jpg

An Overview of PTH’s Pharmaceutical and Biotechnology Holdings

By

Updated

PTH’s portfolio

The PowerShares DWA Healthcare Momentum ETF (PTH) is a smart beta ETF that invests in stocks that exhibit relatively higher momentum than its peers. It invests the majority of its assets in the components of its index, the Dorsey Wright Healthcare Technical Leaders Index.

The index provider assigns a rank to each stock, with the stocks exhibiting the maximum upward momentum having the highest ranks. The index then includes the top 30 ranked stocks in its portfolio. Currently, PTH manages a total net asset of $246 million. The top ten stocks represent 43.6% of PTH’s total portfolio.

Holdings components

PTH is majorly invested in pharmaceutical companies, with 43.2% of its funds invested in pharmaceutical stocks. The biotechnology subsector comes next with a total share of 28.3%. Radius Health (RDUS), Regeneron Pharmaceuticals (REGN), Anacor Pharmaceuticals (ANAC), DexCom (DXCM), and Allergan (AGN) are PTH’s top five holdings.

Moving averages

PTH’s total biotechnological sector includes shares such as Regeneron Pharmaceuticals (REGN), Prothena (PRTA), and Newlink Genetics (NLNK). It’s trading above its 20-day and 50-day moving averages but below its 100-day moving average.

PTH’s pharmaceutical sector, with holdings such as Supernus Pharmaceuticals (SUPN), Sucampo Pharmaceuticals (SCMP), and Radius Health (RDUS), is trading above its 20-day, 50-day, and 100-day moving averages.

PTH’s healthcare product stocks are trading above their 20-day, 50-day, and 100-day moving averages. Healthcare-services stocks are trading above their 20-day moving average but below their 50-day and 100-day moving averages.

More From Market Realist